Microfluidic evaluation of red cells collected and stored in modified processing solutions used in blood banking.

The most recent American Association of Blood Banks survey found that 40,000 units of blood are required daily for general medicine, hematology/oncology, surgery, and for accident and trauma victims. While blood transfusions are an extremely important component of critical healthcare, complications associated with transfusion of blood components still exist. It is well-established that the red blood cell (RBC) undergoes many physical and chemical changes during storage. Increased oxidative stress, formation of advanced glycation endproducts, and microparticle formation are all known to occur during RBC storage. Furthermore, it is also known that patients who receive a transfusion have reduced levels of available nitric oxide (NO), a major determinant in blood flow. However, the origin of this reduced NO bioavailability is not completely understood. Here, we show that a simple modification to the glucose concentration in the solutions used to process whole blood for subsequent RBC storage results in a remarkable change in the ability of these cells to stimulate NO. In a controlled in vitro microflow system, we discovered that storage of RBCs in normoglycemic versions of standard storage solutions resulted in RBC-derived ATP release values 4 weeks into storage that were significantly greater than day 1 release values for those RBCs stored in conventional solutions. During the same storage duration, microfluidic technologies enabled measurements of endothelium-derived NO that were stimulated by the ATP release from the stored RBCs. In comparison to currently accepted processing solutions, the NO production increased by more than 25% in the presence of the RBCs stored in the normoglycemic storage solutions. Control experiments using inhibitors of ATP release from the RBCs, or ATP binding to the endothelium, strongly suggest that the increased NO production by the endothelium is directly related to the ability of the stored RBCs to release ATP. We anticipate these findings to represent a starting point in controlling glucose levels in solutions used for blood component storage, especially considering that current solutions contain glucose at levels that are nearly 20-fold greater than blood glucose levels of a healthy human, and even 10-fold greater than levels found in diabetic bloodstreams.

[1]  Jerry E Squires,et al.  Risks of transfusion. , 2011, Southern medical journal.

[2]  J. Stamler,et al.  Nitric oxide in RBCs , 2002, Transfusion.

[3]  Christopher G Ellis,et al.  Erythrocytes: oxygen sensors and modulators of vascular tone. , 2009, Physiology.

[4]  David J Singel,et al.  Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemoglobin. , 2005, Annual review of physiology.

[5]  Dana M Spence,et al.  Deformation-induced release of ATP from erythrocytes in a poly(dimethylsiloxane)-based microchip with channels that mimic resistance vessels. , 2004, Analytical chemistry.

[6]  D. Christiani,et al.  Clinical predictors of and mortality in acute respiratory distress syndrome: Potential role of red cell transfusion* , 2005, Critical care medicine.

[7]  M. L. Ellsworth,et al.  Deformation-induced ATP release from red blood cells requires CFTR activity. , 1998, American journal of physiology. Heart and circulatory physiology.

[8]  H. Bäumert,et al.  PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses. , 1992, European journal of pharmacology.

[9]  R. Sawant,et al.  Red cell hemolysis during processing and storage , 2007, Asian journal of transfusion science.

[10]  J. Hess.  Red cell storage: when is better not good enough? , 2009, Blood transfusion = Trasfusione del sangue.

[11]  T. Forrester,et al.  Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. , 1992, Cardiovascular research.

[12]  J. Hokanson,et al.  Use of red blood cells older than five days for neonatal transfusion. , 1991, Journal of perinatology : official journal of the California Perinatal Association.

[13]  J. Twisk,et al.  Red blood cell transfusion in critically ill children is independently associated with increased mortality , 2007, Intensive Care Medicine.

[14]  D. Fergusson,et al.  Clinical consequences of red cell storage in the critically ill , 2006, Transfusion.

[15]  James L. Newman,et al.  Red blood cells stored for increasing periods produce progressive impairments in nitric oxide–mediated vasodilation , 2013, Transfusion.

[16]  Sharifi,et al.  Human plasma and Tirilazad mesylate protect stored human erythrocytes against the oxidative damage of gamma‐irradiation , 2000, Transfusion medicine.

[17]  T. Mihaljevic,et al.  Duration of red-cell storage and complications after cardiac surgery. , 2008, The New England journal of medicine.

[18]  R. Sprague,et al.  Impaired Release of ATP from Red Blood Cells of Humans with Primary Pulmonary Hypertension , 2001, Experimental biology and medicine.

[19]  Janet S. Lee,et al.  Advanced glycation end products on stored red blood cells increase endothelial reactive oxygen species generation through interaction with receptor for advanced glycation end products , 2010, Transfusion.

[20]  J. Wautier,et al.  DIABETIC ERYTHROCYTES BEARING ADVANCED GLYCATION END PRODUCTS INDUCE VASCULAR DYSFUNCTIONS , 1996 .

[21]  C. Silliman,et al.  Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury , 2011, Transfusion.

[22]  G. Wells,et al.  A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. , 1999, The New England journal of medicine.

[23]  G. Whitesides,et al.  Fabrication of microfluidic systems in poly(dimethylsiloxane) , 2000, Electrophoresis.

[24]  M. Engelgau,et al.  Screening for type 2 diabetes. , 2000, Diabetes care.

[25]  M. Brecher,et al.  Effects of 3‐5 log10 pre‐storage leucocyte depletion on red cell storage and metabolism , 1994, British journal of haematology.

[26]  M. L. Ellsworth,et al.  Red blood cell-derived ATP as a regulator of skeletal muscle perfusion. , 2004, Medicine and science in sports and exercise.

[27]  M L Ellsworth,et al.  The red blood cell as an oxygen sensor: what is the evidence? , 2000, Acta physiologica Scandinavica.

[28]  C. Silliman,et al.  Proteomic analyses of human plasma: Venus versus Mars , 2012, Transfusion.

[29]  D. Spence,et al.  Red blood cell stimulation of platelet nitric oxide production indicated by quantitative monitoring of the communication between cells in the bloodstream. , 2007, Analytical chemistry.

[30]  Claude A Piantadosi,et al.  How do red blood cells cause hypoxic vasodilation? The SNO-hemoglobin paradigm. , 2006, American journal of physiology. Heart and circulatory physiology.

[31]  R. Sprague,et al.  Reduced Expression of Gi in Erythrocytes of Humans With Type 2 Diabetes Is Associated With Impairment of Both cAMP Generation and ATP Release , 2006, Diabetes.

[32]  D. Spence,et al.  Metal-activated C-peptide facilitates glucose clearance and the release of a nitric oxide stimulus via the GLUT1 transporter , 2007, Diabetologia.

[33]  R. Sprague,et al.  ATP: the red blood cell link to NO and local control of the pulmonary circulation. , 1996, The American journal of physiology.

[34]  D. Spence,et al.  Measuring the simultaneous effects of hypoxia and deformation on ATP release from erythrocytes. , 2008, The Analyst.

[35]  T. McMahon,et al.  Impaired adenosine-5′-triphosphate release from red blood cells promotes their adhesion to endothelial cells: A mechanism of hypoxemia after transfusion* , 2011, Critical care medicine.

[36]  John D Roback,et al.  Insufficient nitric oxide bioavailability: a hypothesis to explain adverse effects of red blood cell transfusion , 2011, Transfusion.

[37]  D. Spence,et al.  Hydroxyurea stimulates the release of ATP from rabbit erythrocytes through an increase in calcium and nitric oxide production. , 2010, European journal of pharmacology.

[38]  B. Spiess,et al.  Risks of transfusion: outcome focus , 2004, Transfusion.

[39]  Ognjen Gajic,et al.  Red blood cell storage lesion. , 2009, Bosnian journal of basic medical sciences.

[40]  S. Moncada,et al.  Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells. , 1991, Biochemical and biophysical research communications.

[41]  R. Sprague,et al.  Expression of the heterotrimeric G protein Gi and ATP release are impaired in erythrocytes of humans with diabetes mellitus. , 2006, Advances in experimental medicine and biology.